The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran
Crossref DOI link: https://doi.org/10.1007/s40199-019-00292-1
Published Online: 2019-07-31
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Amirsadri, Mohammadreza http://orcid.org/0000-0002-0475-4446
Mousavi, Sarah
Karimipour, Ali
Text and Data Mining valid from 2019-07-31
Version of Record valid from 2019-07-31
Article History
Received: 13 April 2019
Accepted: 22 July 2019
First Online: 31 July 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.